New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
VBI Vaccines Inc.
VBIV
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

2M

Biotechnology

Next Earning date - 12 Nov 2024

2M

Biotechnology

Next Earning date - 12 Nov 2024

0.07USD
Shape-0.07 ( -50.87%)
favorite-chart

Relative Strenght

17
favorite-chart

Volume Buzz

233%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

95%

Quote Panel

Shape
Updated October 26, 2024
1W % 1M % 3M -96.40 % 1Y -96.61 %

Key Metrics

Shape
  • Market Cap

    1.87M


  • Shares Outstanding

    28.68M


  • Share in Float

    26.73M


  • Dividende

    0


  • Earning Date

    12 Nov 2024


  • Price Target

    0.0653


  • Average Volume

    8.39M


  • Beta

    2.171


  • Range

    0.0574-1.35


  • Industry

    Biotechnology


  • Website

    https://www.vbivaccines.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.20x

P/S Ratio

-0.29x

P/B Ratio

-9.3

Debt/Equity

-881.8%

Net Margin

$-3.5

EPS

How VBIV compares to sector?

P/E Ratio

Relative Strength

Shape

VBIV

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$34M

Shape2711%

2025-Revenue

$0.28

Shape62%

2025-EPS

$34M

Shape-190%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Zacks Investment Research

upgrade

Previous: Not converted

2022-04-26

Now: Hold

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

N/A

-5.41
vs -2.10

Q3.22

arrow
arrow

N/A

-2.70
vs -1.80

Q4.22

arrow
arrow

N/A

-2.40
vs -2.10

Q1.23

arrow
arrow

N/A

-2.43
vs -2.40

Q2.23

arrow
arrow

N/A

-2.17
vs -5.41

Q3.23

arrow
arrow

N/A

-0.38
vs -2.70

Q4.23

arrow
arrow

N/A

-2.40
vs -2.40

Q1.24

arrow
arrow

N/A

-0.55
vs -2.43

Q3.24

arrow
arrow

N/A

-0.32
vs -0.38

Q4.24

arrow
arrow

N/A

-0.22
vs -2.40

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

+144%

346K  vs 142K

Q3.22

arrow
arrow

+196%

317K  vs 107K

Q4.22

arrow
arrow

+262%

293K  vs 81K

Q1.23

arrow
arrow

+285%

485K  vs 126K

Q2.23

arrow
arrow

+108%

720K  vs 346K

Q3.23

arrow
arrow

+1990%

6.6M  vs 317K

Q4.23

arrow
arrow

+191%

853K  vs 293K

Q1.24

arrow
arrow

+150%

1.2M  vs 485K

Q3.24

arrow
arrow

-52%

3.2M  vs 6.6M

Q4.24

arrow
arrow

+355%

3.9M  vs 853K

Return on EquityShape

status-upQoQ

Q2.22

arrow
arrow

-64%

-0.64
vs -0.20

Q3.22

arrow
arrow

-33%

-0.33
vs -0.64

Q4.22

arrow
arrow

-31%

-0.31
vs -0.33

Q1.23

arrow
arrow

-83%

-0.83
vs -0.31

Q2.23

arrow
arrow

-511%

-5.11
vs -0.83

Q3.23

arrow
arrow

-103%

-1.03
vs -5.11

Q4.23

arrow
arrow

0%

-0.00
vs -1.03

Q1.24

arrow
arrow

+327%

3.27
vs -0.00

Institutionnal OwnershipShape

status-upQoQ

Q3.21

arrow
arrow

132

132
vs 143

-8%

Q4.21

arrow
arrow

137

137
vs 132

4%

Q1.22

arrow
arrow

130

130
vs 137

-5%

Q2.22

arrow
arrow

131

131
vs 130

1%

Q3.22

arrow
arrow

122

122
vs 131

-7%

Q4.22

arrow
arrow

112

112
vs 122

-8%

Q1.23

arrow
arrow

91

91
vs 112

-19%

Q2.23

arrow
arrow

2

2
vs 91

-98%

Earnings Growth

Latest News